My Cart

HLA-A*0201 & B2M & HPV16-E7

Product Inquiry

HLA-A*0201 & B2M & HPV16-E7 Background

Human papillomavirus (HPV) is A kind of papillomavirus belonging to the milk polypoid virus family. It is a spherical DNA virus, which can cause the proliferation of squamous epithelium of human skin mucosa. HPV(human papillomavirus) for common warts, genital warts (condyloma acuminatum), and other symptoms. There are many types of human papillomavirus (HPV), with HPV 16 and 18 being high-risk types known to significantly increase the risk of cervical, vaginal and vulvar cancers in women and men. The human HLA-A*0201 HPV (YMLDLQPET) tetramer protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and YMLDLQPET peptide of the HPV.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BosakitugBSI-045B; TQC-2731; TQC2731Phase 3 ClinicalBiosion IncNasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic
Details
EcleralimabCSJ-117; NOV-14Phase 2 ClinicalNovartis Pharma AgAsthma; Pulmonary Disease, Chronic Obstructive
Details
WIN-1001XWIN-1001XPhase 2 ClinicalWhanin Pharmaceutical Co LtdNerve Degeneration; Parkinson Disease
Details
PF-07275315PF-07275315Phase 2 ClinicalPfizer IncDermatitis, Atopic
Details
LunsekimigSAR-443765Phase 2 ClinicalSanofiNasal Polyps; Asthma; Sinusitis; Inflammation
Details
AZD-8630AZD-8630; AMG-104Phase 2 ClinicalAstrazeneca Plc, Amgen IncAsthma
Details
SHR-1905SHR-1905; AIO-001Phase 2 ClinicalNasal Polyps; Respiratory Tract Diseases; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive
Details
CM-326(Connaught Biomedical Technology)CM-326Phase 2 ClinicalKeymed Biosciences Co LtdNose Diseases; Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic
Details
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
Details
HBM-9378SKB378; HBM-9378Phase 1 ClinicalHarbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co LtdAsthma
Details
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdAsthma
Details
IBI-3002IBI3002; IBI-3002Phase 1 ClinicalInnovent Biologics(Suzhou) Co LtdAsthma
Details
GB-0895GB-0895Phase 1 ClinicalImmune System Diseases; Asthma
Details
STSA-1201STSA-1201; STSA1201Phase 1 ClinicalAsthma
Details
LQ043HLQ043HPhase 1 ClinicalShanghai Novamab Biopharmaceuticals Co LtdAsthma
Details
GR2002GR2002Phase 1 ClinicalGenrix (Shanghai) Biopharmaceutical Co LtdNasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic
Details
QX-008NQX008N; QX-008NPhase 1 ClinicalQyuns Therapeutics Co LtdAsthma; Pulmonary Disease, Chronic Obstructive
Details
BD-9BD-9Biolojic Design Inc
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
TezepelumabAMG-157; MEDI-9929ApprovedAmgen IncTezspireUnited StatesAsthmaAstrazeneca Ab2021-12-17Eosinophilic Esophagitis; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; Sinusitis; Asthma; Granulomatosis with Polyangiitis; Lung Diseases; Immune System Diseases; Chronic Urticaria; Respiratory Tract Diseases; Nasal Polyps; Anaphylaxis; Carcinoma; Lung Diseases, Obstructive
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland